ArticleInvestigational new drugs2018

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.

Michael Carducci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.